Figure 2.

Outcomes in patients who undergo neoadjuvant therapy. Of those patients with potentially resectable pancreatic tumors who undergo chemoradiation, 71% went on to undergo complete surgical resection. Reasons for not undergoing complete resection included declaration of distant metastases, prohibitive performance status, anatomically unresectable locally-advanced tumor, and patient refusal.